| 36866753 | <i>In ovo</i> chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma. | Oncol Rep | 2023 |
| 36866753 | <i>In ovo</i> chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma. | Oncol Rep | 2023 |
| 35949602 | Association of high cellular expression and plasma concentration of angiopoietin-like 4 with tongue cancer lung metastasis and poor prognosis. | Oncol Lett | 2022 |
| 35949602 | Association of high cellular expression and plasma concentration of angiopoietin-like 4 with tongue cancer lung metastasis and poor prognosis. | Oncol Lett | 2022 |
| 35727889 | The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity. | Pediatr Int | 2022 |
| 35727889 | The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity. | Pediatr Int | 2022 |
| 34187933 | Negative correlation of single-cell <i>PAX3:FOXO1</i> expression with tumorigenicity in rhabdomyosarcoma. | Life Sci Alliance | 2021 |
| 33609318 | Proposal of a novel H category-based classification of colorectal liver metastases based on a Japanese nationwide survey. | J Hepatobiliary Pancreat Sci | 2021 |
| 34187933 | Negative correlation of single-cell <i>PAX3:FOXO1</i> expression with tumorigenicity in rhabdomyosarcoma. | Life Sci Alliance | 2021 |
| 33816783 | Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma. | Mol Ther Oncolytics | 2021 |
| 34552155 | Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma. | Sci Rep | 2021 |
| 34472721 | Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma. | Cancer Med | 2021 |
| 33816783 | Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma. | Mol Ther Oncolytics | 2021 |
| 33609318 | Proposal of a novel H category-based classification of colorectal liver metastases based on a Japanese nationwide survey. | J Hepatobiliary Pancreat Sci | 2021 |
| 34472721 | Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma. | Cancer Med | 2021 |
| 34552155 | Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma. | Sci Rep | 2021 |
| 32294127 | Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method. | PLoS One | 2020 |
| 32294127 | Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method. | PLoS One | 2020 |
| 32489328 | Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells. | Cancer Cell Int | 2020 |
| 32847975 | The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of <i>NOXA</i>. | Mol Cancer Ther | 2020 |
| 33163518 | Does laparoscopic liver resection for colorectal liver metastases provide a true survival benefit compared with open liver resection? | Hepatobiliary Surg Nutr | 2020 |
| 33163518 | Does laparoscopic liver resection for colorectal liver metastases provide a true survival benefit compared with open liver resection? | Hepatobiliary Surg Nutr | 2020 |
| 32847975 | The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of <i>NOXA</i>. | Mol Cancer Ther | 2020 |
| 32489328 | Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells. | Cancer Cell Int | 2020 |
| 30365145 | OBPâ¿¿801, a novel histone deacetylase inhibitor, induces Mâ¿¿phase arrest and apoptosis in rhabdomyosarcoma cells. | Oncol Rep | 2019 |
| 30655847 | Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion. | Oncol Lett | 2019 |
| 30365145 | OBPâ¿¿801, a novel histone deacetylase inhibitor, induces Mâ¿¿phase arrest and apoptosis in rhabdomyosarcoma cells. | Oncol Rep | 2019 |
| 30904164 | Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma. | Biochem Biophys Res Commun | 2019 |
| 30720122 | [Erratum] OBPâ¿¿801, a novel histone deacetylase inhibitor, induces Mâ¿¿phase arrest and apoptosis in rhabdomyosarcoma cells. | Oncol Rep | 2019 |
| 31053863 | A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients. | Jpn J Clin Oncol | 2019 |
| 31053863 | A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients. | Jpn J Clin Oncol | 2019 |
| 30904164 | Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma. | Biochem Biophys Res Commun | 2019 |
| 30720122 | [Erratum] OBPâ¿¿801, a novel histone deacetylase inhibitor, induces Mâ¿¿phase arrest and apoptosis in rhabdomyosarcoma cells. | Oncol Rep | 2019 |
| 30655847 | Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion. | Oncol Lett | 2019 |
| 29277819 | Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination. | Anticancer Res | 2018 |
| 29277819 | Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination. | Anticancer Res | 2018 |
| 27840956 | MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells. | Oncol Rep | 2017 |
| 28981396 | Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA. | Nucleic Acid Ther | 2017 |
| 27840956 | MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells. | Oncol Rep | 2017 |
| 28181419 | Anterior approach for right hepatectomy with hanging maneuver for hepatocellular carcinoma: a multi-institutional propensity score-matching study. | J Hepatobiliary Pancreat Sci | 2017 |
| 28181419 | Anterior approach for right hepatectomy with hanging maneuver for hepatocellular carcinoma: a multi-institutional propensity score-matching study. | J Hepatobiliary Pancreat Sci | 2017 |
| 28981396 | Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA. | Nucleic Acid Ther | 2017 |
| 27107976 | Portal Vein Embolization Followed by Right-Side Hemihepatectomy for Hepatocellular Carcinoma Patients: A Japanese Multi-Institutional Study. | J Am Coll Surg | 2016 |
| 27107976 | Portal Vein Embolization Followed by Right-Side Hemihepatectomy for Hepatocellular Carcinoma Patients: A Japanese Multi-Institutional Study. | J Am Coll Surg | 2016 |
| 27255663 | IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. | Sci Rep | 2016 |
| 26494574 | Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis. | Breast Cancer | 2016 |
| 27895761 | C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy. | Oncol Lett | 2016 |
| 26494574 | Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis. | Breast Cancer | 2016 |
| 27895761 | C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy. | Oncol Lett | 2016 |
| 27255663 | IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. | Sci Rep | 2016 |